Altogether, these results suggest that TNF-α released from Cl-IB-MECA-treated CD8+ T cells or after Cl-IB-MECA administration induced LCs activation/influx in the melanoma tissue, which could, in turn, facilitate the T cell responses in vivo. This evidence concerns the gene TNF and melanoma.